TP53 and breast cancer: However, the significant increase of p53 in the OC users of the BC patients could be a response to the damage produced by the cancer manifestation89 whereby p53-mediated responses to DNA damage in pre-γ-radiated mice increased dramatically following treatment with estrogen and progesterone through the TGF-β-dependent pathways.